COMMUNIQUÉS West-GlobeNewswire

Working Behind the Scenes: Supreme Cannabis Builds Strong Core Business -- CFN Media
15/08/2018
SEATTLE, Aug. 15, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
Hemispherx Reports Six Months Ended June 30, 2018 Financial Results and Provides Business Update
15/08/2018
OCALA, Fla., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, has announced [...]
First Choice Healthcare Solutions Reports Second Quarter 2018 Results
15/08/2018
MELBOURNE, Fla., Aug. 15, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("First Choice" or the "Company"), a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]
Acology Shows Strong Quarter; 33% Business Increase; Canada Booming
15/08/2018
CORONA, Calif., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Acology’s latest quarterly report has been released. Here are some of the highlights: Business is up 33% over same period last year and trending higher Sales exceeded $1 [...]
MPX to Moderate Panel on “Pharmaceutical Cannabis in Canada”
15/08/2018
Event co-hosted by MPX’s pharmaceutical affiliate Salus BioPharma; Explores Current Canadian Climate for Cannabis TORONTO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE [...]
Evolus Expands Role of Chief Medical Officer Rui Avelar, MD with Appointment as Head of R&D
15/08/2018
IRVINE, Calif., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced the appointment of Chief Medical Officer Rui Avelar, MD, as Head of Research [...]
Evolus, Inc. Announces Full Exercise and Closing of Underwriters’ Overallotment Option
15/08/2018
IRVINE, Calif., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS) (“Evolus”) today announced that the underwriters of Evolus’ previously announced public offering that initially closed on July 23, 2018, have [...]
Spine Injury Solutions Announces Results for the Second Quarter Ended June 30, 2018
15/08/2018
HOUSTON, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), announces financial results for Q2, 2018. Financial Highlights – three month period ended June 30, 2018 Revenues for the quarter [...]
resTORbio Appoints Jeffrey Chodakewitz, M.D., to its Board of Directors
15/08/2018
Brings extensive experience in clinical and pipeline development to resTORbio’s Board BOSTON, Aug. 15, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq:TORC), a clinical-stage biopharmaceutical company focused on [...]
VBI Vaccines Appoints Christopher McNulty as Chief Financial Officer and Head of Business Development
15/08/2018
CAMBRIDGE, Mass., Aug. 15, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company, today announced the appointment of Christopher McNulty as Chief Financial [...]
Maverick Technology Solutions Completes Reverse Merger Becoming a Publicly Traded Company
15/08/2018
RENO, Nev., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Maverick Technology Solutions, developer and manufacturer of the ROSINBOMB brand of industry leading consumer and commercial rosin presses and technology, announced the [...]
Catalyst Biosciences Announces Updated Positive Interim Data at the 2018 Hemophilia Drug Development Summit
15/08/2018
Data demonstrates continued efficacy of marzeptacog alfa (activated) in two additional subjects SOUTH SAN FRANCISCO, Calif., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage [...]
SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2018 Financial Results
15/08/2018
NEW YORK, Aug. 15, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]
Avalon GloboCare Provides Second Quarter 2018 Business Update; Reports 32% Increase in Revenues
15/08/2018
FREEHOLD, N.J., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, today announced financial results and provided a business update for the [...]
BioCorRx Provides Business Update for the Second Quarter of 2018
15/08/2018
ANAHEIM, CA, Aug. 15, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update [...]
Delcath Announces Second Quarter Fiscal 2018 Financial Results
15/08/2018
NEW YORK, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces financial results for the [...]
William Demant Holding A/S: Managers' transactions
15/08/2018
Company announcement no 2018-09 15 August 2018 Report on transactions with William Demant Holding A/S shares by senior executives and closely related parties Notification on transactions with William Demant Holding A/S [...]
Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort
15/08/2018
PHILADELPHIA and OXFORD, United Kingdom, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced a favorable review of safety data from [...]
Innovate Biopharmaceuticals Reports Second Quarter 2018 Earnings and Key Corporate Highlights
15/08/2018
Added as a member of the broad-market Russell 3000®, 2000® and Microcap® Indexes Innovate plans to host a Clinical and Scientific Update on September 6, 2018, in New York City Multiple research collaborations with [...]

Pages